Faron Pharmaceuticals Oy (HEL:FARON)
Finland · Delayed Price · Currency is EUR 2.185
-0.035 (-1.58%)
At close: Jan 9, 2026
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of €257.14 million as of January 9, 2026. Its market cap has increased by 18.01% in one year.
Market Cap
257.14M
Enterprise Value
265.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.19
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 76.45M to 257.14M, an increase of 236.37%. That is a compound annual growth rate of 12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 257.14M | 8.92% |
| Dec 31, 2025 | 236.09M | -8.97% |
| Dec 31, 2024 | 259.36M | 7.28% |
| Dec 29, 2023 | 241.77M | 19.52% |
| Dec 30, 2022 | 202.28M | 19.31% |
| Dec 31, 2021 | 169.54M | 24.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orion Oyj | 9.29B |
| Terveystalo Oyj | 1.24B |
| Revenio Group Oyj | 607.88M |
| Pihlajalinna Oyj | 323.71M |
| Oriola Oyj | 220.44M |
| Nightingale Health Oyj | 120.20M |
| Nexstim | 98.46M |
| Nanoform Finland Oyj | 85.58M |